Senior Research Manager

Key Information

Reporting to: Navita Somaiah

Duration of Contract: Fixed Term for 24 months in the first instance

Hours per week: 35 hours per week (less than full time applications will be considered on an individual basis) 

This role is eligible for ICR Sponsorship. Support will be provided for costs associated with Visa application. If you are considering relocating to the UK, further information can be found here. 

Job Details

Under the guidance of Dr. Navita Somaiah, we are seeking to recruit a Senior Research Manager to contribute to research development and delivery. The successful candidate will play a key role in protocol development, research funding applications and regulatory issues for clinical and translational research undertaken by Dr Navita Somaiah and the wider Breast Radiotherapy Unit. 

About you

The successful candidate must have:

• Proven experience of working on oncology or radiotherapy clinical trials or experience of oncology data management 
• Experience of working in accordance with ICH-GCP regulatory standards for the conduct of clinical trials and UK Research Governance
• Excellent ability to manage trial logistics and variety of tasks at any given time
• Highly organised, ability to adapt to a dynamic clinical environment
• Excellent interpersonal skills and team-working skills

Department/Directorate Information

The Division of Radiotherapy and Imaging is investigating new imaging methods to diagnose cancer, and ways in which advances in technology and molecular biology can improve radiation treatment. It is also increasingly concerned with the use of imaging to evaluate the response to treatment in vivo, through techniques measuring aspects of tumour biology.

Translational Breast Radiobiology Group

Dr. Navita Somaiah is a group leader (clinician scientist) at The Institute of Cancer Research, London, and an honorary clinical oncology consultant at The Royal Marsden, Breast Unit. Her team works on optimisation of radiotherapy by improving tumour response whilst minimising normal tissue toxicity for more personalised treatments. She leads several national/ international phase I/II clinical trials with a focus on maximising translational read-outs to understand radiation-induced changes in the tumour microenvironment and identify biomarkers of response/resistance to improve therapeutic efficacy. 

What we offer

• A dynamic and supportive research environment
• Access to state-of-the-art facilities and professional development opportunities
• Collaboration with leading researchers in the field
• Competitive salary and pension

We encourage all applicants to access the job pack attached for more detailed information regarding this role. For an informal discussion regarding the role, please contact Navita Somaiah or Lone Gothard for further information by emailing navita.somaiah@icr.ac.uk or lone.gothard@icr.ac.uk, respectively.